Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Anemia prevalence was high in adult patients with HIV infection on HAART, with female sex, older age, and nonsuppressed viral load status identified as significant predictors.

The following is a summary of “Drug-drug interactions between antiretrovirals and hormonal contraception: An updated ...

The 40th annual AIDS Walk Los Angeles will take place Sunday in a very different world than when it first started.

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

Jefferies analyst Akash Tewari has assigned their bullish stance on ARVN stock, giving a Buy rating yesterday. Akash Tewari’s rating is ...

The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...

High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

Despite past performance issues, Arvinas has a solid cash runway. Learn more about ARVN stock's potential and why a cautious ...

Patients living with HIV in Barcelona, Spain have seen a decrease in mortality of patients in critically ill condition ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...